Lisa Hammerle

Lisa Hammerle has extensive work experience in the scientific field. Lisa is currently working as a Scientist at Immusoft since April 2023. Previously, they held roles at various companies including Bristol Myers Squibb, Novo Nordisk, PhaseRx, Amgen, and the University of Washington. At Bristol Myers Squibb, they worked as a Scientist and Senior Associate Scientist, focusing on studying drug combinations for AML and B-cell lymphoma in a translational research setting, with a primary focus on antibody-dependent cellular phagocytosis (ADCP). Lisa also characterized novel mRNA nanoparticles for an orphan liver disease program as a Temporary Research Associate IV at PhaseRx. In their previous role at Amgen, they served as a Sr. Associate Scientist and Associate Scientist, contributing to various scientific projects. Lisa started their career in 1998 as a Research Technologist at the University of Washington in the Department of Medicine.

Lisa Hammerle has a Bachelor of Science (BS) degree in Cell/Cellular and Molecular Biology from the University of Washington. Additionally, they also hold a Bachelor of Science (BS) degree in Environmental Science from Western Washington University. No specific start or end years for these degrees are provided.